Blood test detects ovarian cancer early

	Tweet

Researchers have developed what they believe is the first blood test that accurately detects ovarian cancer at an early stage.

“The ability to recognize almost 100 percent of new tumors will have a major impact on the high death rates of this cancer,” senior author Dr. Gil Mor, from Yale University School of Medicine in New Haven, Connecticut, said in a statement. “We hope this test will become the standard of care for women having routine examinations.”

In 2005, Mor’s team first described a panel of biomarkers that can detect stage I and II ovarian cancer. 

In the present trial, reported in the medical journal Clinical Cancer Research, the researchers expanded the panel from four proteins to six, and used a sophisticated assay system to measure protein levels in 362 healthy women and 156 patients newly diagnosed with ovarian cancer.

Alone, none of the biomarkers could distinguish the cancer patients from the healthy comparison group, the researchers report. When all six biomarkers were measured, however, the test identified 95 percent of the cancer patients.

A larger evaluation of the biomarker assay is currently underway.

SOURCE: Clinical Cancer Research, February 15, 2008.

RELATED STORIES:
TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer   Wayne State proves targeted tumor freezing therapy increases ovarian cancer survival   Cancer stem cells recruit normal stem cells to fuel ovarian cancer, U-M study finds   FDA clears biomarker test for ovarian cancer   Ovarian Cancer Screening Not Catching Early Disease   Nanoparticle-Delivered “Suicide” Genes Slowed Ovarian Tumor Growth   Researchers Identify and Shut Down Protein that Fuels Ovarian Cancer   Specialists provide best outcome for ovarian cancer   Excess weight worsens ovarian cancer prognosis   Motor protein may offer promise in ovarian cancer treatment   Birth after cancer treatment with removal and storage of ovary   Symptom screening plus a simple blood test improves early detection of ovarian cancer   New drug comb may lengthen ovarian cancer survival   Researchers find possible genetic keys to surviving epithelial ovarian cancer   Ovarian cancer survival influenced by MD specialty   More study needed on vitamin D-ovarian cancer link   Nanotech gene therapy kills ovarian cancer in mice   Ovarian Cancer: the Not-so-silent Killer   Low dose naltrexone (LDN): Harnessing the body’s own chemistry to treat human ovarian cancer   New Antibody Offers Hope for Treating Ovarian, Breast Cancer   Ovarian cancer screening saves few lives   Bloating, pain may precede ovarian cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]